DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 4101 - 4125 of 62743 in total
Disease ID Disease Name Gene Symbol ▼ Gene ID Gene Name UniProt ID
C0027066 Myoclonus ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0018784 Sensorineural Hearing Loss (disorder) ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0038273 Stereotypic Movement Disorder ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C3714756 Intellectual Disability ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0270790 Quadriparesis ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0038220 Status Epilepticus ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0520966 Abnormal coordination ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C1857276 Trichohepatoenteric Syndrome ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0028738 Nystagmus ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C4317295 Congenital disorder of glycosylation type 1s ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0025958 Microcephaly ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0339143 Thyroid associated opthalmopathies ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0013384 Dyskinetic syndrome ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C3665347 Visual Impairment ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0029124 Optic Atrophy ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0007789 Cerebral Palsy ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0494475 Tonic - clonic seizures ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0037773 Spastic Paraplegia, Hereditary ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0003864 Arthritis ST3GAL5 8869 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 Q9UNP4
C0011849 Diabetes Mellitus ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011847 Diabetes ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C1306459 Primary malignant neoplasm ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0020456 Hyperglycemia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0002395 Alzheimer's Disease ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C0011265 Presenile dementia ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024